Issue 1/2024
Content (22 Articles)
Dapagliflozin for Atrial Fibrillation
Na Li, Mihail G. Chelu, Yochai Birnbaum
P2Y12 Inhibitors in STEMI Patients — One Size Does Not Fit All
Rajiv C. Patel, Jeffrey E. Jones, George A. Stouffer
High BMI: Another Barrier to Rapid Platelet Inhibition After STEMI PCI
Kenneth M. Zabel, James C. Blankenship
Differential Proteomic Profiles of Coronary Serum Exosomes in Acute Myocardial Infarction Patients with or Without Diabetes Mellitus: ANGPTL6 Accelerates Regeneration of Endothelial Cells Treated with Rapamycin via MAPK Pathways
Weizong Wang, Yixin Zhao, Pengju Zhu, Xiaomeng Jia, Cong Wang, Qingbin Zhang, Hao Li, Jiangrong Wang, Yinglong Hou
Colchicine Inhibits NETs and Alleviates Cardiac Remodeling after Acute Myocardial Infarction
Yue-wei Li, Si-xu Chen, Ying Yang, Zeng-hui Zhang, Wei-bin Zhou, Yu-na Huang, Zhao-qi Huang, Jia-qi He, Ting-feng Chen, Jing-feng Wang, Zhao-yu Liu, Yang-xin Chen
The Acid Sphingomyelinase Inhibitor Amitriptyline Ameliorates TNF-α-Induced Endothelial Dysfunction
Yang Ji, Jing Chen, Lihua Pang, Changnong Chen, Jinhao Ye, Hao Liu, Huanzhen Chen, Songhui Zhang, Shaojun Liu, Benrong Liu, Chuanfang Cheng, Shiming Liu, Yun Zhong
The SGLT2i Dapagliflozin Reduces RV Mass Independent of Changes in RV Pressure Induced by Pulmonary Artery Banding
Kim A. Connelly, Ellen Wu, Aylin Visram, Mark K. Friedberg, Sri Nagarjun Batchu, Veera Ganesh Yerra, Kerri Thai, Linda Nghiem, Yanling Zhang, Golam Kabir, J. F. Desjardins, Andrew Advani, Richard E. Gilbert
Sulfated Galactofucan from Sargassum Thunbergii Attenuates Atherosclerosis by Suppressing Inflammation Via the TLR4/MyD88/NF-κB Signaling Pathway
Kefu Zhu, Xihao Wang, Yingzheng Weng, Genxiang Mao, Yizhong Bao, Jiangjie Lou, Shaoze Wu, Weihua Jin, Lijiang Tang
Effect of Dapagliflozin on the Outcome of Radiofrequency Catheter Ablation in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation
Fangyuan Luo, Liping Sun, Zhe Wang, Yuekun Zhang, Jiaju Li, Yingwei Chen, Jianzeng Dong
Effect of Clinical and Genetic Factors on the Development of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) in Egyptian Patients Receiving Beta-Blockers
Dina M. K. El Gindy, Mohamed H. Solayman, Ramy Khorshid, Mona F. Schaalan, Lamia M. El Wakeel
Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study
Rachel Eikelboom, Richard P. Whitlock, Serena Sibilio, Francis Nguyen, Richard Perez, Jeffrey I. Weitz, Emilie Belley-Cote
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
Ulrich Laufs, Andreas L. Birkenfeld, Uwe Fraass, Bernd Hohenstein, Carsten Siegert, Jens Klotsche, Elisabeth Steinhagen-Thiessen, David Pittrow, Stefan Dexl, Sunnhild Salmen, Volker J. J. Schettler, Klaus G. Parhofer, Sebastian Noé, Ulrike Spengler, Franz-Rudolf Fendler, Anselm Bäumer, Norbert Schön, Tilman Unger, Jens Taggeselle, Andreas Schwittay, Ulf Janseen, Frank Menzel, Christoph Axthelm, Andreas Wilke, Antje Spens, Ayham Al-Zoebi, Volker J.J. Schettler, Toralf Schwarz, Armin Jansen, Bernd Hohenstein, Alexander Stadelmann, Karin Eberhand, Katrin Borucki, Elisabeth Steinhagen-Thiessen, Axel Schlitt, Markus Knittel, Ann-Cathrin Koschker, Alexander Mann, Hans-Holger Ebert, Mohsen Tekiyeh, Katrin Gebauer, Ralf Spitthöver, Andrea Beigel, Ulrich Laufs, David Sinning, Norbert Jahnke, Beate Wild, Detlef Gysan, Johannes Ruef, Matthias Weißbrodt, Andreas Birkenfeld, Holger Killat, Steffen Bischoff, Johannes Beckermann, Ina Wittig, Jens Gerth, Peter Salbach, Dirk Raddatz, Wolfgang Ries, Markolf Hanefeld, Johannes Haas, Ilka Simon-Wager, Christian Zugck, Thomas Twisselmann, Volker Neumann, Markus Brode, Jens Ringel, Beate Schulze, Hansjörg Rothe, Wolfram Oettler, Alexander Stöckl, Sven Meyer, Sebastian Keßler, Rüdiger Meesters, Michael Brandt, Ksenija Stach-Jablonski, Berthold Amann
The Effects of a Perindopril-Based Regimen in Relation to Statin Use on the Outcomes of Patients with Vascular Disease: a Combined Analysis of the ADVANCE, EUROPA, and PROGRESS Trials
S. P. Radhoe, E. Boersma, M. Bertrand, W. Remme, R. Ferrari, K. Fox, S. MacMahon, J. Chalmers, M. L. Simoons, J. J. Brugts
Medical Therapy After CABG: the Known Knowns, the Known Unknowns, and the Unknown Unknowns
Lauren K. Barron, Marc R. Moon
Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review
Federico Marchini, Graziella Pompei, Emanuele D’Aniello, Andrea Marrone, Serena Caglioni, Simone Biscaglia, Gianluca Campo, Matteo Tebaldi
Therapeutic Strategies Targeting Mitochondrial Dysfunction in Sepsis-induced Cardiomyopathy
Oluwabukunmi Modupe Salami, Olive Habimana, Jin-fu Peng, Guang-Hui Yi
Antacid Therapy in Coronary Artery Disease and Heart Failure: Proton Pump Inhibitors vs. H2 Receptor Blockers
Muzamil Khawaja, Janki Thakker, Riyad Kherallah, Masafumi Kitakaze, Hani Jneid, Dominick J. Angiolillo, Yochai Birnbaum
Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a)
Robert S. Rosenson, J. Antonio G. López, Maria Laura Monsalvo, You Wu, Huei Wang, Santica M. Marcovina
The Effect of Colchicine in Acute Myocardial Infarction
Chunbo Miao, Yanyu Lin, Yingchun Xu
Winding Down the Storm: Could Empagliflozin’s Ion-Dependent Mechanisms Tackle the Ventricular Arrhythmia Burden in Chronic Chagas Cardiomyopathy?
Sergio Alejandro Gómez-Ochoa, Lyda Z. Rojas, Luis Eduardo Echeverría